Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
株式のランク #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
株価
$42.98
最終同期: 2024-06-21
時価総額
$1.62B
変化(1日)
0.01%
変化(1年)
0.00%
IL
取引 Taro Pharmaceutical Industries Ltd. (TARO)

カテゴリー

Taro Pharmaceutical Industries Ltd.(TARO)の発行済株式数
March 2024 時点の発行済株式数 37.58M
Taro Pharmaceutical Industries Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 37.58M です。March 2023 の終わりには、同社は 37.58M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Taro Pharmaceutical Industries Ltd.(TARO)の発行済株式数の履歴(1999 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 37.58M 0.00%
2024 37.58M 0.00%
2023 37.58M -0.15%
2022 37.64M -1.49%
2021 38.21M -0.65%
2020 38.46M -1.36%
2019 38.99M -2.90%
2018 40.16M -2.77%
2017 41.30M -3.58%
2016 42.83M 0.00%
2015 42.83M -3.26%
2014 44.28M -0.90%
2013 44.68M 0.00%
2012 44.68M 10.94%
2010 40.27M 2.65%
2009 39.23M 0.08%
2008 39.20M 12.89%
2007 34.73M 18.33%
2006 29.35M 0.33%
2005 29.25M 0.36%
2004 29.14M 1.03%
2003 28.85M 0.35%
2002 28.75M 22.75%
2001 23.42M 9.33%
2000 21.42M 6.30%
1999 20.15M 0.00%
類似企業や競合他社の発行済株式数